USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Progenics, Inc.
Address:
442 West 44nd Street
New York, NY 10036
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $50,000.00 1
SBIR Phase II $495,000.00 1

Award List:

SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Norman Applezweig , Principal Investigator
Abstract:
N/a

SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$495,000.00
Agency:
HHS
Principal Investigator:
Norman Applezweig , Principal Investigator
Abstract:
The use of -etiocholanolone and -etiocholanolone in aplastic anemia shows promise, but the supply is very limited due to the lack of a good synthesis from readily available material. -etiocholanolone would be less traumatic to the patient, but is not readily available again for the above mentioned… More